We are live on ! Find out more
CWG

C WorldWide Group Portfolio holdings

AUM $4.66B
1-Year Est. Return 11.67%
This Fund
S&P 500
This Quarter Est. Return
+9.48%
1 Year Est. Return
+11.67%
3 Year Est. Return
+62.16%
5 Year Est. Return
+69.96%
10 Year Est. Return
+372.2%
AUM
$8.89B
AUM Growth
+$325M
Cap. Flow
-$399M
Cap. Flow %
-4.48%
Top 10 Hldgs %
74.41%
Holding
100
New
18
Increased
19
Reduced
27
Closed
7

Top Buys

Rank Stock Value
1
SPGI icon
S&P Global
SPGI
+$244M
2
QDEL icon
QuidelOrtho
QDEL
+$33.5M
3
AERI
Aerie Pharmaceuticals
AERI
+$11M
4
MDLZ icon
Mondelez International
MDLZ
+$9.23M
5
HUM icon
Humana
HUM
+$9.03M

Top Sells

Rank Stock Value
1
MSCI icon
MSCI
MSCI
+$253M
2
BABA icon
Alibaba
BABA
+$248M
3
AMZN icon
Amazon
AMZN
+$108M
4
TSM icon
TSMC
TSM
+$27.3M
5
HDB icon
HDFC Bank
HDB
+$27.1M

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 18.57%
2 Financials 17.04%
3 Healthcare 16.43%
4 Consumer Staples 10.86%
5 Technology 9.64%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CVS icon
26
CVS Health
CVS
$133B
$30.1M 0.34%
516,015
– –
ISRG icon
27
Intuitive Surgical
ISRG
$127B
$29.8M 0.33%
125,811
– –
EDU icon
28
New Oriental
EDU
$9.37B
$27.4M 0.31%
183,213
-848
-0.5% -$123K
EW icon
29
Edwards Lifesciences
EW
$49.6B
$27.2M 0.31%
341,311
+54,070
+19% +$4.22M
NVCR icon
30
NovoCure
NVCR
$1.73B
$26.9M 0.3%
241,784
-100,000
-29% -$8M
DXCM icon
31
DexCom
DXCM
$31.5B
$25.6M 0.29%
248,000
– –
CNC icon
32
Centene
CNC
$30.7B
$24.2M 0.27%
414,756
-71,702
-15% -$4.45M
LHCG
33
DELISTED
LHC Group LLC
LHCG
$23.5M 0.26%
110,657
-25,000
-18% -$4.93M
AXNX
34
DELISTED
Axonics, Inc. Common Stock
AXNX
$20.4M 0.23%
400,000
– –
SRPT icon
35
Sarepta Therapeutics
SRPT
$1.57B
$20.4M 0.23%
145,329
– –
TAL icon
36
TAL Education Group
TAL
$6.93B
$20.4M 0.23%
268,352
-1,758
-0.7% -$133K
TFX icon
37
Teleflex
TFX
$6.05B
$19.7M 0.22%
58,000
+5,000
+9% +$1.85M
CHRS icon
38
Coherus Oncology
CHRS
$217M
$19.4M 0.22%
1,058,464
+150,000
+17% +$2.79M
VRTX icon
39
Vertex Pharmaceuticals
VRTX
$121B
$18.7M 0.21%
68,557
– –
ILMN icon
40
Illumina
ILMN
$31B
$17.9M 0.2%
59,601
– –
PODD icon
41
Insulet
PODD
$11.5B
$17.2M 0.19%
72,908
– –
AERI
42
DELISTED
Aerie Pharmaceuticals
AERI
$17.1M 0.19%
1,456,142
+900,000
+162% +$11M
BHVN
43
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
$16.4M 0.18%
251,751
+50,000
+25% +$3.28M
MYOK
44
DELISTED
MyoKardia, Inc. Common Stock
MYOK
$15.9M 0.18%
116,950
– –
MRK icon
45
Merck
MRK
$322B
$15.5M 0.17%
195,691
– –
INSM icon
46
Insmed
INSM
$21.4B
$14.2M 0.16%
443,110
– –
HRTX icon
47
Heron Therapeutics
HRTX
$93.9M
$13.4M 0.15%
902,069
+200,000
+28% +$3.12M
BMRN icon
48
BioMarin Pharmaceuticals
BMRN
$11.6B
$12.5M 0.14%
163,851
– –
GKOS icon
49
Glaukos
GKOS
$9.83B
$12.2M 0.14%
247,212
– –
TXMD icon
50
TherapeuticsMD
TXMD
$23.5M
$9.78M 0.11%
123,797
– –
1
2
3 4

Similar funds

ASC
Atalanta Sosnoff Capital New York $4.66B AUM 41.34% 1-Year Est. Return
MA
Mutual Advisors Omaha, Nebraska $4.67B AUM 17.48% 1-Year Est. Return
EI
EFG International Zurich $4.67B AUM
ACM
Abrams Capital Management Boston, Massachusetts $4.64B AUM 1.52% 1-Year Est. Return
VCM
Voleon Capital Management Berkeley, California $4.64B AUM 38.78% 1-Year Est. Return
CCWM
Cassaday & Co Wealth Management Mclean, Virginia $4.69B AUM 20.56% 1-Year Est. Return
DWM
Dakota Wealth Management Palm Beach Gardens, Florida $4.62B AUM 33.09% 1-Year Est. Return
DCP
Darsana Capital Partners New York $4.7B AUM 50.56% 1-Year Est. Return

C WorldWide Group's Q3 2020 Portfolio in Review

As of Q3 2020, C WorldWide Group held 100 positions worth $8.89B, up 3.8% from $8.57B the previous quarter. Its ten largest holdings account for 74% of the portfolio.

C WorldWide Group withdrew a net $399M in Q3 2020, closing 7 positions and reducing 27 holdings. Its most notable exit was Alibaba, an estimated $248M position sold in full.

By sector, the portfolio is most concentrated in Consumer Discretionary at 19% of assets, down from 21% a quarter earlier, followed by Financials and Healthcare.

Against the trend, C WorldWide Group opened a new position in S&P Global worth $249M.

  • C WorldWide Group's largest Q3 2020 buy was S&P Global: 691,456 shares worth $249M.
  • C WorldWide Group added most to Aerie Pharmaceuticals in Q3 2020, an estimated $11M increase.
  • C WorldWide Group's biggest Q3 2020 reduction was MSCI, cutting an estimated $253M.
  • C WorldWide Group fully exited Alibaba in Q3 2020, selling an estimated $248M.
  • C WorldWide Group's ten largest holdings make up 74% of its $8.89B portfolio in Q3 2020.
  • C WorldWide Group opened 18 new positions and closed 7 in Q3 2020.
  • C WorldWide Group's portfolio value rose 3.8% quarter-over-quarter to $8.89B.

Based on C WorldWide Group's 13F filing for Q3 2020, filed 2 Nov 2020.